Exam Preview for 35296: The Future of Clinical Care (Part 3): Produ

The Future of Clinical Care (Part 3): Products and Services

Please note: exam questions are subject to change.

1. What is Cochlear Link? A secure cloud-based service which allows us to load MAPs directly from participating clinic databases onto a replacement sound processor and ship directly to the recipient. A delicious breakfast sausage. The latest sound processor, equipped to reduce noise for 150% correct on speech perception evaluations. A magnetic tool that physically attaches a processor to a recipient’s clothing so that it does not get lost.
2. The Nucleus 22 cochlear implant recipients Were implanted between 1985 - 1997 Are now able to wear the Nucleus 7 Sound Processor Are able to use the SmartApp available for all Nucleus 7 recipients All of the above
3. Ready-to-Wear is: A fashion line seen in Milan A service that pre-programs processors to ship to recipients when they request an upgrade A waterproof sleeve that allows for swimming Available to a very small number of clinics
4. What is rated IP68 without additional accessories or covers? The Kanso 2 Sound Processor The Nucleus 7 Sound Processor Both of these Neither of these
5. Programming the Kanso 2 and the Nucleus 7 for N22 implant recipients… Requires a lengthy appointment Can only be successfully achieved remotely Requires Custom Sound Pro fitting software Can be done under water
6. Kanso 2 and Nucleus 7 both Allow direct connection to Android and Apple Have dual microphone and SmartSound IQ with SCAN True Wireless and Smart Bimodal Streaming to both ears All of the above
7. Remote Check Is another term for remote programming Enables the recipient to do a quick check at home so the clinician can determine if an in-office appointment is needed Allows recipients to never come to the clinic again Can only be used by Apple iPhone users
8. The Kanso 2 Comes in 5 colors Is solar powered Requires a D battery Is very heavy
9. An example of evidence-based practice is: Using speech perception test outcomes to decide if re-MAPping is required. Adopting new candidacy criteria based on clinical trial data and FDA approval. Following infection control guidelines such as washing hands or wearing gloves. All of the above
10. In order to differentiate the cables, the Nucleus 7 for N22 recipients is: Blue Green Yellow Red